Mutations in the IDH1 gene have been associated with numerous malignancies including lower-grade gliomas as the mutant IDH1 enzyme catalyzes the conversion of α-KG to D-2-hydroxyglutarate (D-2HG), an oncometabolite [26]. This evidence concerns the gene IDH1 and glioma.